BioHealth News Archive
Reflecting on 2020 and Wishing You Happy Holidays
Though it began like any other year, 2020 has proven to be one of the most difficult and frustrating periods of our lifetime. This…
Read MoreUnited Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Dec. 9, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that the United States…
Read MoreGeorge Washington University, US Patent Innovations targeting cancer and Covid in $3.2M corporate research agreement – Washington Business Journal
The university licenses its original patent to the company to develop the product and conduct early-stage clinical trials. Image: Michael Keidar, a mechanical engineer…
Read MoreThe Enactment of Bayh-Dole, An Inside Perspective – IPWatchdog.com | Patents & Patent Law
We caught the tide– but just barely. That the Bayh-Dole Act passed was amazing. That it passed in a lame duck session of Congress…
Read MoreWhere In The World Should I Conduct My Pivotal Clinical Trial? · BioBuzz
The COVID pandemic has certainly forced us to re-think the whole paradigm of conducting clinical trials. From design, site and CRO selection, patient recruitment,…
Read MoreEmmes Announces its Contribution to Second Remdesivir Clinical Trial for COVID-19 | BioSpace
ROCKVILLE, Md., Dec. 14, 2020 /PRNewswire/ -- Emmes today announced that it has conducted the data and statistical analysis for the second iteration of the…
Read MoreAstraZeneca to acquire Alexion for $39 billion in blockbuster deal
AstraZeneca on Saturday said it was acquiring Alexion Pharmaceuticals for $39 billion, marking a significant expansion into the treatment of rare diseases of the…
Read MoreAstraZeneca to acquire Alexion for $39 billion in blockbuster deal
AstraZeneca on Saturday said it was acquiring Alexion Pharmaceuticals for $39 billion, marking a significant expansion into the treatment of rare diseases of the…
Read MoreQiagen, producer of COVID tests, to expand in Germantown, add 300 jobs – Maryland Daily Record
Qiagen, an international life sciences company that provides molecular sample and assay technologies, is expanding its United States headquarters in Germantown to accommodate increased…
Read MoreUSM COVID Research & Innovation Task Force Launches Student PSA Public Health Challenge – USM
Baltimore, Md. (Dec. 11, 2020) – The University System of Maryland (USM) COVID Research and Innovation Task Force is bringing together people, expertise, and…
Read MoreConnected DMV President & CEO Stu Solomon joins Rich Bendis on BioTalk
Stu Solomon, President & CEO, Connected DMV joins BioTalk to discuss formation of the Strategic Renewal Task Force, their Covid-19 Pandemic Pivot, the Global…
Read MoreEIR Feedback (BHI) – Wednesday, December 16, 2020 – Biohealth Innovation
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreEIR Feedback (BHI) – Wednesday, December 16, 2020 – Biohealth Innovation
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreSBIR Virtual Office Hours – Wednesday 12/09/20 (BHI and MCEDC) – Biohealth Innovation
Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding to advance your technology? Learn more about whether or…
Read MoreFirst use of nView medical’s novel 3D imaging technology in pediatric spine surgery
Children’s National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids. The innovation, insta-3D™ imaging from company…
Read More